跳至主要内容
临床试验/NCT04066972
NCT04066972已完成不适用

Intensive Aerobic and Task-specific Training to Restore Walking and Boost Neuroplasticity Among People With MS-related Walking Disability: a Proof of Principle Trial

Memorial University of Newfoundland2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2018年7月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
10
试验地点
2
主要终点
Feasibility of conducting vigorous cool room treadmill training

研究概览

简要总结

People with multiple sclerosis (MS) are often offered walking aids and compensatory strategies rather than restorative rehabilitation. We have developed a cool room treadmill training method that uses body-weight support that people with MS fatigue and heat sensitivity can tolerate. Our previous research shows that people with advanced MS use three times more energy for essential tasks such as walking. This project will test whether 10 weeks of body-weight supported treadmill training in a room cooled to 16°C improves walking, fitness and fatigue in people with advanced MS.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • clinically definite MS
  • relapse-free in the previous 3 months
  • requiring ambulatory assistive devices (EDSS 6.0-7.0)
  • negative PAR-Q screen for risk factors
  • greater than 6-weeks post Botulinum Toxin injection (if received) in the lower extremity

排除标准

  • pregnancy or intention of becoming pregnant
  • finished a drug/device study in the last 30 days
  • over 75 years of age
  • unable to control bowel and bladder on physical exertion
  • currently attending physical rehabilitation
  • having no difficulty walking in the community (self-selected walking speed >120 cm/s)

研究组 & 干预措施

Single arm

Experimental

干预措施: Body-weight supported treadmill training in a room cooled to 16°C (Other)

结局指标

主要结局

Feasibility of conducting vigorous cool room treadmill training

时间窗: 10 weeks

Recruitment and retention rates

次要结局

  • Timed 25 foot walk test(Following completion of the 10-week exercise intervention and 3-months post-exercise intervention)
  • Maximal oxygen consumption during graded exercise test(Following completion of the 10-week exercise intervention and 3-months post-exercise intervention)
  • Health-related quality of life assessed using 36-Item Short-Form Health Survey(Following completion of the 10-week exercise intervention and 3-months post-exercise intervention)
  • Serum interleukin-6(Following completion of the 10-week exercise intervention and 3-months post-exercise intervention)
  • Spatiotemporal parameters of gait measured while walking at fast and self-selected pace(Following completion of the 10-week exercise intervention and 3-months post-exercise intervention)
  • Fatigue severity scale(Following completion of the 10-week exercise intervention and 3-months post-exercise intervention)
  • Body composition measured using dual energy x-ray absorptiometry(Following completion of the 10-week exercise intervention and 3-months post-exercise intervention)
  • Modified fatigue impact scale(Following completion of the 10-week exercise intervention and 3-months post-exercise intervention)
  • Serum brain derived neurotrophic factor(Following completion of the 10-week exercise intervention and 3-months post-exercise intervention)
  • Montreal cognitive assessment(Following completion of the 10-week exercise intervention and 3-months post-exercise intervention)
  • Corticospinal excitability measured using transcranial magnetic stimulation(Following completion of the 10-week exercise intervention and 3-months post-exercise intervention)
  • Magnetization transfer ratio measured using magnetic resonance imaging(Following completion of the 10-week exercise intervention and 3-months post-exercise intervention)
  • Aerobic cost of walking(Following completion of the 10-week exercise intervention and 3-months post-exercise intervention)
  • Step counts(Following completion of the 10-week exercise intervention and 3-months post-exercise intervention)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Michelle Ploughman

Assistant Professor of Medicine

Memorial University of Newfoundland

研究点 (2)

Loading locations...

相似试验